No recent analyst price targets found for BIOCON.NS.
Latest News for BIOCON.NS

Shreehas Tambe nombrado CEO y Director General de Biocon Limited con efectos a partir del 1 de abril de 2026
/PRNewswire/ -- Biocon Limited (BSE: 532523) (NSE: BIOCON) anunció hoy el nombramiento de Shreehas Tambe como Director Ejecutivo (Chief Executive Officer) y
PRNewsWire • Mar 27, 2026

Shreehas Tambe übernimmt zum 1. April 2026 die Rolle des Executive Officer und Managing Director bei Biocon Limited
/PRNewswire/ -- Biocon Limited (BSE: 532523) (NSE: BIOCON) gab heute die Ernennung von Shreehas Tambe zum Chief Executive Officer und Managing Director bekannt
PRNewsWire • Mar 27, 2026
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BIOCON.NS.
Senate Trading
No Senate trades found for BIOCON.NS.
U.S. House Trading
No House trades found for BIOCON.NS.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
